rs1747682

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006214.4(PHYH):​c.153C>T​(p.Asn51Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.993 in 1,313,394 control chromosomes in the GnomAD database, including 648,562 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.97 ( 71952 hom., cov: 31)
Exomes 𝑓: 1.0 ( 576610 hom. )

Consequence

PHYH
NM_006214.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.222

Publications

23 publications found
Variant links:
Genes affected
PHYH (HGNC:8940): (phytanoyl-CoA 2-hydroxylase) This gene is a member of the PhyH family and encodes a peroxisomal protein that is involved in the alpha-oxidation of 3-methyl branched fatty acids. Specifically, this protein converts phytanoyl-CoA to 2-hydroxyphytanoyl-CoA. Mutations in this gene have been associated with Refsum disease (RD) and deficient protein activity has been associated with Zellweger syndrome and rhizomelic chondrodysplasia punctata. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
PHYH Gene-Disease associations (from GenCC):
  • adult Refsum disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P, Orphanet
  • phytanoyl-CoA hydroxylase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 10-13295588-G-A is Benign according to our data. Variant chr10-13295588-G-A is described in ClinVar as Benign. ClinVar VariationId is 129891.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.222 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHYHNM_006214.4 linkc.153C>T p.Asn51Asn synonymous_variant Exon 3 of 9 ENST00000263038.9 NP_006205.1 O14832-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHYHENST00000263038.9 linkc.153C>T p.Asn51Asn synonymous_variant Exon 3 of 9 1 NM_006214.4 ENSP00000263038.4 O14832-1

Frequencies

GnomAD3 genomes
AF:
0.971
AC:
147752
AN:
152128
Hom.:
71907
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.900
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.991
Gnomad ASJ
AF:
0.995
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.999
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
1.00
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.977
GnomAD2 exomes
AF:
0.992
AC:
249233
AN:
251144
AF XY:
0.994
show subpopulations
Gnomad AFR exome
AF:
0.900
Gnomad AMR exome
AF:
0.996
Gnomad ASJ exome
AF:
0.996
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.995
GnomAD4 exome
AF:
0.996
AC:
1156972
AN:
1161148
Hom.:
576610
Cov.:
17
AF XY:
0.997
AC XY:
590830
AN XY:
592650
show subpopulations
African (AFR)
AF:
0.888
AC:
24916
AN:
28052
American (AMR)
AF:
0.996
AC:
44163
AN:
44354
Ashkenazi Jewish (ASJ)
AF:
0.996
AC:
24176
AN:
24272
East Asian (EAS)
AF:
1.00
AC:
38328
AN:
38328
South Asian (SAS)
AF:
0.999
AC:
79945
AN:
80028
European-Finnish (FIN)
AF:
1.00
AC:
53171
AN:
53172
Middle Eastern (MID)
AF:
0.994
AC:
5086
AN:
5118
European-Non Finnish (NFE)
AF:
1.00
AC:
837254
AN:
837464
Other (OTH)
AF:
0.992
AC:
49933
AN:
50360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.448
Heterozygous variant carriers
0
164
328
491
655
819
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14328
28656
42984
57312
71640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.971
AC:
147856
AN:
152246
Hom.:
71952
Cov.:
31
AF XY:
0.972
AC XY:
72357
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.900
AC:
37357
AN:
41504
American (AMR)
AF:
0.991
AC:
15138
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.995
AC:
3455
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5184
AN:
5184
South Asian (SAS)
AF:
0.999
AC:
4823
AN:
4830
European-Finnish (FIN)
AF:
1.00
AC:
10610
AN:
10610
Middle Eastern (MID)
AF:
1.00
AC:
294
AN:
294
European-Non Finnish (NFE)
AF:
1.00
AC:
68016
AN:
68042
Other (OTH)
AF:
0.977
AC:
2067
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
193
385
578
770
963
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.991
Hom.:
94636
Bravo
AF:
0.967
Asia WGS
AF:
0.996
AC:
3464
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 17, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 21, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Phytanic acid storage disease Benign:3
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
4.8
DANN
Benign
0.61
PhyloP100
0.22
Mutation Taster
=298/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1747682; hg19: chr10-13337588; COSMIC: COSV108080965; COSMIC: COSV108080965; API